Department of Neurology, UCLA, Los Angeles, CA, USA.
Department of Pathology, UC Davis, Davis, CA, USA.
Neuron. 2023 Sep 20;111(18):2863-2880.e6. doi: 10.1016/j.neuron.2023.06.009. Epub 2023 Jul 13.
Changes in the function of inhibitory interneurons (INs) during cortical development could contribute to the pathophysiology of neurodevelopmental disorders. Using all-optical in vivo approaches, we find that parvalbumin (PV) INs and their immature precursors are hypoactive and transiently decoupled from excitatory neurons in postnatal mouse somatosensory cortex (S1) of Fmr1 KO mice, a model of fragile X syndrome (FXS). This leads to a loss of parvalbumin INs (PV-INs) in both mice and humans with FXS. Increasing the activity of future PV-INs in neonatal Fmr1 KO mice restores PV-IN density and ameliorates transcriptional dysregulation in S1, but not circuit dysfunction. Critically, administering an allosteric modulator of Kv3.1 channels after the S1 critical period does rescue circuit dynamics and tactile defensiveness. Symptoms in FXS and related disorders could be mitigated by targeting PV-INs.
在皮质发育过程中抑制性中间神经元 (INs) 的功能变化可能导致神经发育障碍的病理生理学改变。使用全光学体内方法,我们发现脆性 X 综合征 (FXS) 模型 Fmr1 KO 小鼠的出生后体感皮层 (S1) 中的 PV 中间神经元及其未成熟前体表现出低活性,并与兴奋性神经元短暂分离。这导致 FXS 小鼠和人类的 PV 中间神经元 (PV-INs) 丢失。在新生 Fmr1 KO 小鼠中增加未来 PV-IN 的活性可恢复 PV-IN 密度并改善 S1 中的转录失调,但不能改善电路功能障碍。至关重要的是,在 S1 关键期后施用 Kv3.1 通道的变构调节剂可挽救电路动力学和触觉防御。通过靶向 PV-INs 可以减轻 FXS 和相关疾病的症状。